Prime Medicine, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -29.62%-6,566.61%
EBIT Margin -17.89%-6,787.36%
EBITDA Margin -65.45%-6,566.07%
Operating Margin -17.89%-6,787.36%
Net Margin -97.02%-6,566.61%
FCF Margin -118.68%-4,363.36%
Efficiency
Assets Average 331.08M277.08M245.68M
Equity Average -76.95M80.02M224.67M143.11M
Invested Capital 2.34M-156.24M316.27M133.07M153.15M
Asset Utilization Ratio 0.01
Leverage & Solvency
Equity Ratio -0.520.880.690.51
Valuation
Enterprise Value -36.98M-253.66M1,520.04M746.08M195.55M
Market Capitalization 1,806.13M862.29M382.99M
Return Ratios
Return on Sales -0.66%-65.67%
Return on Capital Employed -0.38%-0.93%-0.97%
Return on Invested Capital 1.09%-1.45%-0.91%
Return on Assets -0.37%-0.72%-0.80%
Return on Equity 2.15%-1.52%-0.88%-1.37%